Monoclonal antibodies are
biotechnology's biggest comeback story. Until the late 1990s, monoclonals, which had been dubbed magic bullets, appeared to be shot from a gun that couldn't
Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.




See what we're tweeting about






Comments
Add Comment